Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
OTC Markets OTCPK - Delayed Quote USD

Mosaic ImmunoEngineering, Inc. (CPMV)

Compare
0.9800
+0.3180
+(48.04%)
At close: February 21 at 3:00:00 PM EST
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
5/31/2020
Operating Expense
1,005.1160
1,399.7680
2,627.5220
3,501.1660
996.0190
Operating Income
-1,005.1160
-1,399.7680
-2,627.5220
-3,501.1660
-996.0190
Net Non Operating Interest Income Expense
-80.3810
-85.7670
-151.5480
-160.1120
12.0680
Other Income Expense
21
479.7000
400.6000
-20.8000
-74.9770
Pretax Income
-1,064.4970
-1,005.8350
-2,378.4700
-3,682.0780
-1,058.9280
Tax Provision
--
2.4000
2.4000
2.4000
1.6000
Net Income Common Stockholders
-1,064.4970
-1,008.2350
-2,380.8700
-3,684.4780
-1,060.5280
Diluted NI Available to Com Stockholders
-1,064.4970
-1,008.2350
-2,380.8700
-3,684.4780
-1,060.5280
Basic EPS
-0.15
-0.14
-0.33
-0.55
-1.33
Diluted EPS
-0.15
-0.14
-0.33
-0.55
-1.33
Basic Average Shares
7,236.4470
7,236.4470
7,235.6090
6,712.6750
797.0960
Diluted Average Shares
7,236.4470
7,236.4470
7,235.6090
6,712.6750
797.0960
Total Operating Income as Reported
-1,005.1160
-1,399.7680
-2,627.5220
-3,501.1660
--
Total Expenses
1,005.1160
1,399.7680
2,627.5220
3,501.1660
996.0190
Net Income from Continuing & Discontinued Operation
-1,064.4970
-1,008.2350
-2,380.8700
-3,684.4780
-1,060.5280
Normalized Income
-1,064.4970
-1,045.1280
-2,426.3740
-3,669.2940
-1,060.5280
Interest Income
0.0100
3.4080
0.0330
0.0360
12.0680
Interest Expense
80.3910
89.1750
151.5810
160.1480
--
Net Interest Income
-80.3810
-85.7670
-151.5480
-160.1120
12.0680
EBIT
-984.1060
-916.6600
-2,226.8890
-3,521.9300
-996.0190
EBITDA
-984.1060
-916.6600
-2,226.8890
-3,521.9300
-995.5310
Reconciled Depreciation
--
--
--
--
0.4880
Net Income from Continuing Operation Net Minority Interest
-1,064.4970
-1,008.2350
-2,380.8700
-3,684.4780
-1,060.5280
Total Unusual Items Excluding Goodwill
--
46.7000
57.6000
-20.8000
--
Total Unusual Items
--
46.7000
57.6000
-20.8000
--
Normalized EBITDA
-984.1060
-963.3600
-2,284.4890
-3,501.1300
-995.5310
Tax Rate for Calcs
--
0.0002
0.0002
0.0003
0.0003
Tax Effect of Unusual Items
--
9.8070
12.0960
-5.6160
--
5/31/2020 - 1/2/2013

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

OTLC Oncotelic Therapeutics, Inc.
0.0300
-13.04%
 
PMCB PharmaCyte Biotech, Inc.
1.7600
-2.76%
 
ENTX Entera Bio Ltd.
2.1000
-4.11%
 
CELZ Creative Medical Technology Holdings, Inc.
5.40
-9.85%
 
NWBO Northwest Biotherapeutics, Inc.
0.2500
+2.00%
 
CVM CEL-SCI Corporation
0.3960
-6.38%
 
VKTX Viking Therapeutics, Inc.
34.07
+7.71%